Interestingly, PCS with overexpression of both Rictor and Neu2 exhibited reduced mTORC2 formation and Hh pathway activity as well as decreased cancer stem cell-specific markers, suggesting a dominant role of Neu2 over Rictor and emphasizing the involvement of sialic acids in the mTORC2-Hh pathway also. This evidence concerns the gene RICTOR and cancer.